Product Information
MUCUS RELIEF ER 1,200 MG TAB is a generic product labeled by Rugby Laboratories, priced at $0.4316 per EA under NDC 00536124971. Its NADAC has been published 54 times since Sep 24, 2025.
FDA first approved this application on Aug 21, 2023.
Strength
1200 mg/1
Manufacturer
Rugby LaboratoriesNDC
00536124971
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESINApproval Type
Generic (ANDA)
FDA Application
ANDA217780FDA Approved
8/21/2023
On Market Since
4/21/2025
Pharmacological Classes
Price Statistics
The NADAC for MUCUS RELIEF ER 1,200 MG TAB has been published 54 times since Sep 24, 2025, and over the history we have for it it has declined 5.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4316 per EA |
|---|---|
| All-time high | $0.4613 (Nov 12, 2025) |
| All-time low | $0.4044 (Jan 21, 2026) |
| 52-week high | $0.4613 |
| 52-week low | $0.4044 |
| Median price | $0.4446 |
| Average price | $0.4386 |
| Largest weekly change | +6.3% (Apr 22, 2026) |
| Weeks tracked | 54 |
| Tracking since | Sep 24, 2025 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rugby Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MUCUS RELIEF ER 1,200 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for MUCUS RELIEF ER 1,200 MG TAB, manufactured by Rugby Laboratories, is $0.4316 per EA (NDC 00536124971), effective Sep 30, 2026.
How has the price of MUCUS RELIEF ER 1,200 MG TAB changed over time?
Over the history we have for it, the NADAC for MUCUS RELIEF ER 1,200 MG TAB has declined 5.7%. It has been tracked across 54 weekly CMS publications since Sep 24, 2025.
What are the highest and lowest recorded NADAC prices for MUCUS RELIEF ER 1,200 MG TAB?
Since Sep 24, 2025, the NADAC for MUCUS RELIEF ER 1,200 MG TAB has ranged from a low of $0.4044 (Jan 21, 2026) to a high of $0.4613 (Nov 12, 2025), with a median of $0.4446 per EA.
Are there cheaper alternatives to MUCUS RELIEF ER 1,200 MG TAB?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MUCUS RELIEF ER 1,200 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures MUCUS RELIEF ER 1,200 MG TAB?
MUCUS RELIEF ER 1,200 MG TAB (NDC 00536124971) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.